Early: Phase I/IIa Article 26 November 2025 MHRA’s regulatory renaissance: Why the UK is now a strategic hub for early clinical trials Download PDF Share Share Share on Facebook Share on Linkedin Share on Twitter Share on Threads Share via Email Copy link to clipboard